TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 2160379

Group type: EXPERIMENTAL
Intervention: Trimethoprim-polymyxin B sulphate cream (0.17 mg/g trimethoprim and 10,000 IU/g polymyxin B sulphate)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Fusidic acid cream (20 mg/g)
Number of subjects: 64
Study: 6107292

Group type: EXPERIMENTAL
Intervention: Temazepam
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Barbiturate
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Flurazepam
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5

Group type: COMPARATOR
Intervention: No capsule
Number of subjects: 5
Study: 30916230

Group type: EXPERIMENTAL
Intervention: Remote nursing monitoring through telephone calls and conventional monitoring
Number of subjects: 101

Group type: COMPARATOR
Intervention: Conventional monitoring
Number of subjects: 101
Study: 28233585

Group type: EXPERIMENTAL
Intervention: Trust-conveying communication style
Number of subjects: 97

Group type: COMPARATOR
Intervention: Standard communication style
Number of subjects: 97
Study: 25369277

Group type: EXPERIMENTAL
Intervention: CoQ10 (600 mg) daily for 11 days
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 24106864

Group type: EXPERIMENTAL
Intervention: Extensive supervised training program
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Short version ('3 times 3') home-based training
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (waiting group)
Number of subjects: 54
Study: 21859489

Group type: EXPERIMENTAL
Intervention: Multidisciplinary biopsychosocial educational group intervention (MBEGI)
Number of subjects: 932

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 932
Study: 18834816

Group type: EXPERIMENTAL
Intervention: Rewarming to a nasopharyngeal temperature of 37 degrees C (Group A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Rewarming to a nasopharyngeal temperature of 33 degrees C (Group B)
Number of subjects: 80
Study: 17720074

Group type: EXPERIMENTAL
Intervention: Cataract surgery with combined primary posterior continuous curvilinear capsulorhexis (PPCCC) and posterior optic buttonholing (POBH)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional cataract surgery with in-the-bag IOL implantation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Use of IOP-lowering drops
Number of subjects: 50
Study: 14506077

Group type: EXPERIMENTAL
Intervention: GLU (6.4% carbohydrate beverage)
Number of subjects: 7

Group type: COMPARATOR
Intervention: CON (sweet placebo beverage)
Number of subjects: 7
Study: 11226791

Group type: EXPERIMENTAL
Intervention: Cefotaxime 0.25% (0.4 mL)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Balanced Salt Solution (BSS) (control)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Cefotaxime 0.25%
Number of subjects: 66
Study: 9714026

Group type: EXPERIMENTAL
Intervention: Mass Balance Index (MBI) for patients with nPCR <0.8
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Mass Balance Index (MBI) for patients with nPCR >0.8
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Kt/V for patients with nPCR <0.8
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Kt/V for patients with nPCR >0.8
Number of subjects: 2

Group type: COMPARATOR
Intervention: Comparison of Kt/V between both groups
Number of subjects: 2
Study: 8029191

Group type: EXPERIMENTAL
Intervention: 5 mg folic acid 3 times per week
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 25 mg folic acid 3 times per week
Number of subjects: 30

Group type: COMPARATOR
Intervention: 0 mg folic acid 3 times per week (Control)
Number of subjects: 30
Study: 2645345

Group type: EXPERIMENTAL
Intervention: 3.6% hypertonic saline (HS)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Meth challenge (Meth1)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: HS challenge followed by Meth challenge (Meth2)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Initial HS challenge
Number of subjects: 11
Study: 4552464

Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Dummy tablets (Control)
Number of subjects: 40
Study: 29924701

Group type: EXPERIMENTAL
Intervention: Sprint Interval Exercise (SIE) - 4 × 30 s sprints separated by 4.5 min of active recovery
Number of subjects: 16

Group type: COMPARATOR
Intervention: Continuous Exercise (CE) - 20 min at 65% peak power output
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Both SIE and CE
Number of subjects: 16
Study: 28711457

Group type: EXPERIMENTAL
Intervention: Finger-feeding technique
Number of subjects: 53

Group type: COMPARATOR
Intervention: Cup feeding method
Number of subjects: 53
Study: 26179754

Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg once-weekly
Number of subjects: 361

Group type: COMPARATOR
Intervention: Insulin glargine once-daily
Number of subjects: 361
Study: 23334470

Group type: EXPERIMENTAL
Intervention: minimally invasive percutaneous antegrade ureterolithotripsy (mini-PCNL)
Number of subjects: 59

Group type: COMPARATOR
Intervention: retrograde ureterolithotripsy (URSL)
Number of subjects: 59
Study: 21196806

Group type: EXPERIMENTAL
Intervention: Day hospital treatment
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Inpatient treatment
Number of subjects: 57

Group type: COMPARATOR
Intervention: Outpatient treatment
Number of subjects: 57
Study: 18474884

Group type: EXPERIMENTAL
Intervention: Decision aid for communicating absolute cardiovascular disease risk and shared decision making, provided to 550 patients through 44 physicians attending 2 CME sessions.
Number of subjects: 1132

Group type: COMPARATOR
Intervention: Control group received 1 CME session on an alternative topic, involving 582 patients.
Number of subjects: 1132
Study: 15738298

Group type: EXPERIMENTAL
Intervention: Topical decongestant and external dilator strip
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo and sham treatment
Number of subjects: 10
Study: 15321623

Group type: EXPERIMENTAL
Intervention: Thromboembolic deterrent stockings (TED) and sequential compression device (SCD)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no TED/SCD)
Number of subjects: 0
Study: 9842764

Group type: EXPERIMENTAL
Intervention: Dyslexic group D1
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Dyslexic group D2
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Both dyslexic groups
Number of subjects: 185

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Dyslexic groups
Number of subjects: 185

Group type: EXPERIMENTAL
Intervention: Dyslexic group D1 and D2
Number of subjects: 185
Study: 7511106

Group type: EXPERIMENTAL
Intervention: Nifedipine (10 mg t.i.d.)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (no medication)
Number of subjects: 24
Study: 2499203

Group type: EXPERIMENTAL
Intervention: 10 mg/kg praziquantel
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: 20 mg/kg praziquantel
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: 30 mg/kg praziquantel
Number of subjects: 280

Group type: EXPERIMENTAL
Intervention: 40 mg/kg praziquantel
Number of subjects: 280
Study: 29858412

Group type: EXPERIMENTAL
Intervention: Ten Top Tips
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Do Something Different
Number of subjects: 15
Study: 27587528

Group type: EXPERIMENTAL
Intervention: Fibular nail
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard ORIF
Number of subjects: 100
Study: 23362335

Group type: EXPERIMENTAL
Intervention: Clown intervention (children accompanied by parents and two clowns)
Number of subjects: 196

Group type: COMPARATOR
Intervention: Comparison group (children accompanied by parents only)
Number of subjects: 196
Study: 22848346

Group type: EXPERIMENTAL
Intervention: Medical male circumcision (MMC)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: GUD of unknown etiology
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Fusobacteria (Fusobacterium spp. and Sneathia spp.)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Oxobacter spp. and Anaerovorax spp.
Number of subjects: 59

Group type: COMPARATOR
Intervention: Uncircumcised men
Number of subjects: 59
Study: 19751234

Group type: EXPERIMENTAL
Intervention: Home parental programme (HPP) lasting approximately 12 weeks, involving visual-motor activities at home.
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group receiving consultation in the classroom only.
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Home parental programme (HPP)
Number of subjects: 45
Study: 18771484

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: 9‐OH risperidone
Number of subjects: 490
Study: 16084181

Group type: EXPERIMENTAL
Intervention: Access to drug samples
Number of subjects: 29

Group type: COMPARATOR
Intervention: No access to drug samples
Number of subjects: 29
Study: 12120185

Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg twice daily
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tegaserod
Number of subjects: 0
Study: 9732652

Group type: EXPERIMENTAL
Intervention: Education group
Number of subjects: 252

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 252

Group type: COMPARATOR
Intervention: Comparison group 1
Number of subjects: 252

Group type: COMPARATOR
Intervention: Comparison group 2
Number of subjects: 252
Study: 8277302

Group type: EXPERIMENTAL
Intervention: Consumer-delivered case management services
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Participation in social activities
Number of subjects: 0
Study: 3176837

Group type: EXPERIMENTAL
Intervention: Buprenorphine (0.6 mg in 20 ml NaCl)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Naloxone (0.4 mg in 20 ml NaCl)
Number of subjects: 32
Study: 31743542

Group type: EXPERIMENTAL
Intervention: 1% BOI lotion (ceramide HS) applied once a day for 6 months
Number of subjects: 58
Study: 29122255

Group type: EXPERIMENTAL
Intervention: TENS
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Diadynamic currents (DD)
Number of subjects: 55
Study: 25240788

Group type: EXPERIMENTAL
Intervention: Patient navigator intervention (up to five home visits)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (received a packet of linguistically matched materials on palliative care)
Number of subjects: 64
Study: 22905878

Group type: EXPERIMENTAL
Intervention: Perampanel (up to 12 mg/day)
Number of subjects: 1218

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1218
Study: 20860867

Group type: EXPERIMENTAL
Intervention: Cognitive Enhancement Therapy (CET)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Enriched Supportive Therapy (Control)
Number of subjects: 58
Study: 19579946

Group type: EXPERIMENTAL
Intervention: Daily iron supplementation (15 drops)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Weekly iron supplementation (30 drops)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Comparison of daily vs weekly iron supplementation
Number of subjects: 100
Study: 17998182

Group type: EXPERIMENTAL
Intervention: Minimally-invasive total knee replacement (TKR) approaches (quadriceps-sparing and sub-vastus)
Number of subjects: 198

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 198
Study: 14982566

Group type: EXPERIMENTAL
Intervention: Dextromethorphan (270 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 11338024

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery (pleuropneumonectomy) followed by sequential chemotherapy and radiotherapy
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Supportive care alone
Number of subjects: 3000

Group type: COMPARATOR
Intervention: Single-modality therapy (surgery, radiotherapy, chemotherapy)
Number of subjects: 3000
Study: 9635532

Group type: EXPERIMENTAL
Intervention: Patient reminder intervention
Number of subjects: 5801

Group type: EXPERIMENTAL
Intervention: Physician reminder intervention
Number of subjects: 5801
Study: 8170529

Group type: EXPERIMENTAL
Intervention: quazepam (15-30 mg, median 15 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: triazolam (0.25-0.5 mg, median 0.25 mg)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: quazepam
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: triazolam
Number of subjects: 45

Group type: COMPARATOR
Intervention: both drugs
Number of subjects: 45
Study: 29802174

Group type: EXPERIMENTAL
Intervention: Huaier granule
Number of subjects: 1044

Group type: COMPARATOR
Intervention: Control (no further treatment)
Number of subjects: 1044
Study: 27603376

Group type: COMPARATOR
Intervention: Ropivacaine (R)
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Ropivacaine with fentanyl (R + F)
Number of subjects: 82
Study: 24871477

Group type: EXPERIMENTAL
Intervention: Provegetarian food pattern (FP)
Number of subjects: 7216

Group type: EXPERIMENTAL
Intervention: Updated information on diet
Number of subjects: 7216
Study: 23171639

Group type: EXPERIMENTAL
Intervention: EMiC2 dialyzer
Number of subjects: 11

Group type: COMPARATOR
Intervention: AV 1000S dialyzer
Number of subjects: 11
Study: 20466802

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beet root juice (BR, 5.1 mmol of NO(3)(‐)/day)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Nitrate-rich beet root juice (BR)
Number of subjects: 7
Study: 18776000

Group type: EXPERIMENTAL
Intervention: Implantable cardioverter defibrillators (SCD-HeFT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy alone (COMPANION)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy plus implantable cardioverter defibrillator (COMPANION)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cardiac resynchronization therapy alone (CARE-HF)
Number of subjects: 0
Study: 17161052

Group type: EXPERIMENTAL
Intervention: Invasive treatment strategy
Number of subjects: 2457

Group type: COMPARATOR
Intervention: Noninvasive treatment strategy
Number of subjects: 2457
Study: 14576886

Group type: EXPERIMENTAL
Intervention: AD syringe only
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Mixed (AD syringes used only on non-routine immunization days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sterilizable syringe only (control)
Number of subjects: 15
Study: 10805207

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) via dry powder inhaler (Clickhaler)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (BDP) via pressurized metered-dose inhaler (MDI)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Beclomethasone dipropionate (BDP) via Clickhaler
Number of subjects: 240
Study: 8828933

Group type: EXPERIMENTAL
Intervention: Regular replacement of lenses every 3 months
Number of subjects: 39

Group type: COMPARATOR
Intervention: No scheduled replacement of lenses
Number of subjects: 39
Study: 1349062

Group type: EXPERIMENTAL
Intervention: Self-help rehabilitation programme based on a heart manual
Number of subjects: 176

Group type: COMPARATOR
Intervention: Standard care plus placebo package of information and informal counselling
Number of subjects: 176
Study: 3881203

Group type: EXPERIMENTAL
Intervention: 1,25(OH)2D3, 0.50 micrograms a day
Number of subjects: 70

Group type: COMPARATOR
Intervention: Cyclical estrogen/gestagen
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo + calcium
Number of subjects: 70
Study: 30706142

Group type: EXPERIMENTAL
Intervention: Lovingkindness meditation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Music
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 60
Study: 30408351

Group type: EXPERIMENTAL
Intervention: MJ-Abst (4 weeks of cannabis abstinence, n = 62)
Number of subjects: 88

Group type: COMPARATOR
Intervention: MJ-Mon (monitoring control condition, n = 26)
Number of subjects: 88
Study: 27009822

Group type: EXPERIMENTAL
Intervention: Oral NTHi vaccine (HI-164OV)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 320
Study: 24769011

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin
Number of subjects: 1258

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 1258

Group type: EXPERIMENTAL
Intervention: Insulin-dependent diabetes group
Number of subjects: 1258

Group type: EXPERIMENTAL
Intervention: Chronic hypertension group
Number of subjects: 1258

Group type: EXPERIMENTAL
Intervention: Multiple gestation group
Number of subjects: 1258

Group type: EXPERIMENTAL
Intervention: Previous preeclampsia group
Number of subjects: 1258
Study: 23144819

Group type: EXPERIMENTAL
Intervention: CRS patients with complement defects
Number of subjects: 87

Group type: COMPARATOR
Intervention: Healthy control subjects
Number of subjects: 87
Study: 19943984

Group type: EXPERIMENTAL
Intervention: Champagne wine consumption
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control matched for alcohol, carbohydrate and fruit-derived acid content
Number of subjects: 0
Study: 17106718

Group type: EXPERIMENTAL
Intervention: Bilateral isometric handgrip (IHG) training, 4 contractions at 30% of maximal voluntary effort, 3 times per week for 8 weeks.
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Unilateral isometric handgrip (IHG) training, 4 contractions at 30% of maximal voluntary effort, 3 times per week for 8 weeks.
Number of subjects: 16
Study: 15741989

Group type: EXPERIMENTAL
Intervention: L-carnitine 1 g orally three times a day for 12 weeks
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 12067941

Group type: EXPERIMENTAL
Intervention: H pylori CagA seropositivity in cases (n=201)
Number of subjects: 615

Group type: COMPARATOR
Intervention: H pylori CagA seropositivity in controls (n=414)
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Adjusted analysis for cases
Number of subjects: 615

Group type: EXPERIMENTAL
Intervention: Baseline inflammatory markers in cases and controls
Number of subjects: 615
Study: 9800081

Group type: EXPERIMENTAL
Intervention: Vestibular rehabilitation therapy
Number of subjects: 16
Study: 7638371

Group type: EXPERIMENTAL
Intervention: Salmeterol 25, 50, and 75 micrograms
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Formoterol 12, 24, and 36 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Salmeterol 50 micrograms
Number of subjects: 12

Group type: COMPARATOR
Intervention: Formoterol 12 and 24 micrograms
Number of subjects: 12
Study: 2374566

Group type: EXPERIMENTAL
Intervention: Oleic acid diet
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Trans-fatty-acid diet
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Saturated-fat diet
Number of subjects: 59
Study: 361463

Group type: EXPERIMENTAL
Intervention: Mazindol (2 mg/day for 12 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Mazindol
Number of subjects: 46
Study: 30773048

Group type: EXPERIMENTAL
Intervention: Educational audio intervention
Number of subjects: 713
Study: 31600103

Group type: EXPERIMENTAL
Intervention: Biocellulose wound dressing
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: Carboxymethyl cellulose wound dressing
Number of subjects: 4

Group type: COMPARATOR
Intervention: Normal saline wound dressing
Number of subjects: 4
Study: 28619061

Group type: EXPERIMENTAL
Intervention: Rituximab 1 g intravenously, twice at an interval of 2 weeks
Number of subjects: 116

Group type: COMPARATOR
Intervention: Cyclophosphamide 600 mg/m2 body surface area intravenously, given monthly
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 116

Group type: COMPARATOR
Intervention: Cyclophosphamide
Number of subjects: 116
Study: 26341455

Group type: EXPERIMENTAL
Intervention: Early feeding (fasting for 4 hours after endoscopic therapy)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Delayed feeding (fasting for 48 hours after endoscopic therapy)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Early feeding
Number of subjects: 70

Group type: COMPARATOR
Intervention: Delayed feeding
Number of subjects: 70
Study: 24045029

Group type: EXPERIMENTAL
Intervention: Rumination induction
Number of subjects: 81

Group type: COMPARATOR
Intervention: Distraction
Number of subjects: 81
Study: 20427425

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of a megadose of cholecalciferol (10,000 IU kg(‐1), max 600,000 IU)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Intramuscular injection of a megadose of cholecalciferol
Number of subjects: 40
Study: 18777031

Group type: EXPERIMENTAL
Intervention: AS100 vaccine
Number of subjects: 2770
Study: 16919747

Group type: EXPERIMENTAL
Intervention: Levomethadyl acetate (LAAM), 255-391 mg
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Buprenorphine (BUP), 56-112 mg
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Methadone (METH), 420-700 mg
Number of subjects: 137
Study: 12472796

Group type: COMPARATOR
Intervention: Conventional PD fluid (heat sterilized at pH 5.5)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low GDP PD fluid (sterilized using a multicompartment bag system)
Number of subjects: 0
Study: 10708158

Group type: EXPERIMENTAL
Intervention: Mild hypothermic CPB (34 degrees C)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate hypothermic CPB (28 degrees C)
Number of subjects: 0
Study: 9105981

Group type: EXPERIMENTAL
Intervention: Lumbar epidural narcotics (Group 1, n = 26)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Thoracic epidural narcotics (Group 2, n = 26)
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Both groups received 5 mg of epidural morphine after intubation
Number of subjects: 52
Study: 8478661

Group type: COMPARATOR
Intervention: IL-2/IFN (IL-2 0.8 mg/m2 and IFN 3 x 10(6) U/m2)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: IL-2 alone (1.33 mg/m2)
Number of subjects: 71
Study: 2429335

Group type: EXPERIMENTAL
Intervention: 20 mg piroxicam each morning
Number of subjects: 40

Group type: COMPARATOR
Intervention: 250 mg naproxen twice daily
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Therapeutic exercise (conservative treatment)
Number of subjects: 40
Study: 30870105

Group type: EXPERIMENTAL
Intervention: Implicit condition (assessing automatic suppression)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Explicit condition (assessing controlled suppression)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 126
Study: 28598933

Group type: EXPERIMENTAL
Intervention: Voluntary workplace shoulder exercise program
Number of subjects: 76

Group type: COMPARATOR
Intervention: Control group (similar departments without exercise program)
Number of subjects: 76
Study: 25692797

Group type: EXPERIMENTAL
Intervention: Financial incentives for medication adherence
Number of subjects: 78